Conmed (CNMD) Intangibles (2010 - 2026)

Conmed has reported Intangibles for 17 years, with the latest figure at $573.8 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 5.91% year-over-year to $573.8 million; the trailing twelve-month figure through Mar 2026 stood at $573.8 million (down 5.91% YoY), and the FY2025 full-year result was $582.1 million, down 5.77% from the prior year.
• Intangibles for Q1 2026 stood at $573.8 million, down from $582.1 million in the prior quarter.
• The five-year high for Intangibles was $689.5 million in Q3 2022, with the low at $463.4 million in Q1 2022.
• Historically, Intangibles has averaged $616.4 million across 5 years, with a median of $625.6 million in 2024.
• Annual changes were most pronounced in 2022 — Intangibles slipped 6.17% — and 2023, when it surged 45.34%.
• Conmed's Intangibles stood at $681.8 million in 2022, then dropped by 4.74% to $649.5 million in 2023, then dropped by 4.9% to $617.7 million in 2024, then decreased by 5.77% to $582.1 million in 2025, then dropped by 1.42% to $573.8 million in 2026.
• The last three Intangibles figures came in at $573.8 million (Q1 2026), $582.1 million (Q4 2025), and $593.1 million (Q3 2025), per Business Quant data.